Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Alzheimer's Disease Therapeutics and Diagnostics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Alzheimer's Disease Therapeutics and Diagnosticsmarket, defines the market attractiveness level of Alzheimer's Disease Therapeutics and Diagnostics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Alzheimer's Disease Therapeutics and Diagnostics industry, describes the types of Alzheimer's Disease Therapeutics and Diagnostics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Alzheimer's Disease Therapeutics and Diagnostics market and the development prospects and opportunities of Alzheimer's Disease Therapeutics and Diagnostics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Alzheimer's Disease Therapeutics and Diagnostics market in Chapter 13.
By Player:
Actavis
Daiichi Sankyo
Pfizer
Aricept
TauRx
Eisai
Exelon
Solanezumab
Novartis
Verubecestat
Lundbeck
Gantenerumab
Namenda
By Type:
Biomarkers
Cholinesterase inhibitors
NMDA receptor antagonists
Brain imaging
Blood tests
By End-User:
Drugs Market
Diagnostics Market
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Alzheimer's Disease Therapeutics and Diagnostics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Alzheimer's Disease Therapeutics and Diagnostics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Alzheimer's Disease Therapeutics and Diagnostics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Alzheimer's Disease Therapeutics and Diagnostics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Alzheimer's Disease Therapeutics and Diagnostics Market Analysis and Outlook to 2022
-
7.1 Global Alzheimer's Disease Therapeutics and Diagnostics Consumption (2017-2022)
-
7.2 United States Alzheimer's Disease Therapeutics and Diagnostics Consumption (2017-2022)
-
7.3 Europe Alzheimer's Disease Therapeutics and Diagnostics Consumption (2017-2022)
-
7.4 China Alzheimer's Disease Therapeutics and Diagnostics Consumption (2017-2022)
-
7.5 Japan Alzheimer's Disease Therapeutics and Diagnostics Consumption (2017-2022)
-
7.6 India Alzheimer's Disease Therapeutics and Diagnostics Consumption (2017-2022)
-
7.7 South Korea Alzheimer's Disease Therapeutics and Diagnostics Consumption (2017-2022)
8 Region and Country-wise Alzheimer's Disease Therapeutics and Diagnostics Market Analysis and Outlook to 2028
-
8.1 Global Alzheimer's Disease Therapeutics and Diagnostics Consumption Forecast (2022-2028)
-
8.2 United States Alzheimer's Disease Therapeutics and Diagnostics Consumption Forecast (2022-2028)
-
8.3 Europe Alzheimer's Disease Therapeutics and Diagnostics Consumption Forecast (2022-2028)
-
8.4 China Alzheimer's Disease Therapeutics and Diagnostics Consumption Forecast (2022-2028)
-
8.5 Japan Alzheimer's Disease Therapeutics and Diagnostics Consumption Forecast (2022-2028)
-
8.6 India Alzheimer's Disease Therapeutics and Diagnostics Consumption Forecast (2022-2028)
-
8.7 South Korea Alzheimer's Disease Therapeutics and Diagnostics Consumption Forecast (2022-2028)
9 Global Alzheimer's Disease Therapeutics and Diagnostics Market Outlook by Types and Applications to 2022
-
9.1 Global Alzheimer's Disease Therapeutics and Diagnostics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Biomarkers Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Cholinesterase inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global NMDA receptor antagonists Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Brain imaging Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Blood tests Consumption and Growth Rate (2017-2022)
-
9.2 Global Alzheimer's Disease Therapeutics and Diagnostics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Drugs Market Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Diagnostics Market Consumption and Growth Rate (2017-2022)
10 Global Alzheimer's Disease Therapeutics and Diagnostics Market Outlook by Types and Applications to 2028
-
10.1 Global Alzheimer's Disease Therapeutics and Diagnostics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Biomarkers Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Cholinesterase inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global NMDA receptor antagonists Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Brain imaging Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Blood tests Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Alzheimer's Disease Therapeutics and Diagnostics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Drugs Market Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Diagnostics Market Consumption Forecast and Growth Rate (2022-2028)
11 Global Alzheimer's Disease Therapeutics and Diagnostics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Alzheimer's Disease Therapeutics and Diagnostics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Alzheimer's Disease Therapeutics and Diagnostics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Alzheimer's Disease Therapeutics and Diagnostics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Alzheimer's Disease Therapeutics and Diagnostics Market Competitive Analysis
-
14.1 Actavis
-
14.1.1 Actavis Company Details
-
14.1.2 Actavis Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Actavis Alzheimer's Disease Therapeutics and Diagnostics Product and Service
-
14.2 Daiichi Sankyo
-
14.2.1 Daiichi Sankyo Company Details
-
14.2.2 Daiichi Sankyo Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Daiichi Sankyo Alzheimer's Disease Therapeutics and Diagnostics Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Alzheimer's Disease Therapeutics and Diagnostics Product and Service
-
14.4 Aricept
-
14.4.1 Aricept Company Details
-
14.4.2 Aricept Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Aricept Alzheimer's Disease Therapeutics and Diagnostics Product and Service
-
14.5 TauRx
-
14.5.1 TauRx Company Details
-
14.5.2 TauRx Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 TauRx Alzheimer's Disease Therapeutics and Diagnostics Product and Service
-
14.6 Eisai
-
14.6.1 Eisai Company Details
-
14.6.2 Eisai Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Eisai Alzheimer's Disease Therapeutics and Diagnostics Product and Service
-
14.7 Exelon
-
14.7.1 Exelon Company Details
-
14.7.2 Exelon Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Exelon Alzheimer's Disease Therapeutics and Diagnostics Product and Service
-
14.8 Solanezumab
-
14.8.1 Solanezumab Company Details
-
14.8.2 Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Product and Service
-
14.9 Novartis
-
14.9.1 Novartis Company Details
-
14.9.2 Novartis Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Novartis Alzheimer's Disease Therapeutics and Diagnostics Product and Service
-
14.10 Verubecestat
-
14.10.1 Verubecestat Company Details
-
14.10.2 Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Product and Service
-
14.11 Lundbeck
-
14.11.1 Lundbeck Company Details
-
14.11.2 Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Product and Service
-
14.12 Gantenerumab
-
14.12.1 Gantenerumab Company Details
-
14.12.2 Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Product and Service
-
14.13 Namenda
-
14.13.1 Namenda Company Details
-
14.13.2 Namenda Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Namenda Alzheimer's Disease Therapeutics and Diagnostics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Alzheimer's Disease Therapeutics and Diagnostics
-
Figure Alzheimer's Disease Therapeutics and Diagnostics Picture
-
Table Global Alzheimer's Disease Therapeutics and Diagnostics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Consumption by Country (2017-2022)
-
Figure United States Alzheimer's Disease Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Europe Alzheimer's Disease Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure China Alzheimer's Disease Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure India Alzheimer's Disease Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Alzheimer's Disease Therapeutics and Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Global Alzheimer's Disease Therapeutics and Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure United States Alzheimer's Disease Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Alzheimer's Disease Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Alzheimer's Disease Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Alzheimer's Disease Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Alzheimer's Disease Therapeutics and Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biomarkers Consumption and Growth Rate (2017-2022)
-
Figure Global Cholinesterase inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global NMDA receptor antagonists Consumption and Growth Rate (2017-2022)
-
Figure Global Brain imaging Consumption and Growth Rate (2017-2022)
-
Figure Global Blood tests Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs Market Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostics Market Consumption and Growth Rate (2017-2022)
-
Figure Global Biomarkers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cholinesterase inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NMDA receptor antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Brain imaging Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Blood tests Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugs Market Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostics Market Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Alzheimer's Disease Therapeutics and Diagnostics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Alzheimer's Disease Therapeutics and Diagnostics Export by Region (Top 5 Countries) (2017-2028)
-
Table Actavis (Foundation Year, Company Profile and etc.)
-
Table Actavis Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Actavis Alzheimer's Disease Therapeutics and Diagnostics Product and Service
-
Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)
-
Table Daiichi Sankyo Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Alzheimer's Disease Therapeutics and Diagnostics Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Alzheimer's Disease Therapeutics and Diagnostics Product and Service
-
Table Aricept (Foundation Year, Company Profile and etc.)
-
Table Aricept Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aricept Alzheimer's Disease Therapeutics and Diagnostics Product and Service
-
Table TauRx (Foundation Year, Company Profile and etc.)
-
Table TauRx Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table TauRx Alzheimer's Disease Therapeutics and Diagnostics Product and Service
-
Table Eisai (Foundation Year, Company Profile and etc.)
-
Table Eisai Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Alzheimer's Disease Therapeutics and Diagnostics Product and Service
-
Table Exelon (Foundation Year, Company Profile and etc.)
-
Table Exelon Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Exelon Alzheimer's Disease Therapeutics and Diagnostics Product and Service
-
Table Solanezumab (Foundation Year, Company Profile and etc.)
-
Table Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Alzheimer's Disease Therapeutics and Diagnostics Product and Service
-
Table Verubecestat (Foundation Year, Company Profile and etc.)
-
Table Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Product and Service
-
Table Lundbeck (Foundation Year, Company Profile and etc.)
-
Table Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Product and Service
-
Table Gantenerumab (Foundation Year, Company Profile and etc.)
-
Table Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Product and Service
-
Table Namenda (Foundation Year, Company Profile and etc.)
-
Table Namenda Alzheimer's Disease Therapeutics and Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Namenda Alzheimer's Disease Therapeutics and Diagnostics Product and Service
-
